Microsoft (MSFT)

Marvell Technology projects fiscal 2031 revenue of up to $90 billion on custom AI chip demand, requiring 54% annual growth as investors weigh its premium valuation and hyperscaler dependence.

AI is reshaping software, chips, and memory, and these three tech stocks are riding that wave in very different ways this fall.

AMD trades at an 83x forward P/E versus Broadcom's 30x, but one company's profitability and free cash flow tell a starkly different story.

EMCOR Group, Dycom Industries, and United Rentals sit where AI CapEx meets a skilled labor shortage, turning electricians, fiber crews and equipment into growth.

This company is attacking the artificial intelligence opportunity from multiple angles.

These ETFs take the guesswork out of finding the best quantum computing stock.

Nvidia and the big banks financing its growth disagree about the useful lifespan of its powerful processors.

The software giant's past two lagging streaks ended very differently. Which one does this one look like?

Picking winners and losers in the artificial intelligence industry hasn't been easy.

Las Vegas, Nevada--(Newsfile Corp. - October 6, 2026) - Decentralized Energy Company (DEC), a subsidiary of Decentral Life, Inc. (OTC: WDLF),...

AMD sells its own AI GPUs and server processors to data centers, and Marvell designs the custom chips and networking hardware that cloud providers order to their own specs.

XLK's lower fees and higher dividend yield appeal to cost-conscious investors, while IYW's broader portfolio of 149 holdings offers diversification across the Russell 1000 landscape.

Vistra just landed a conditional $4.2 billion DOE loan. The deal reveals something much bigger for investors in nuclear energy stocks.

These cloud giants recently locked in hundreds of billions in contracted AI spending, and it's starting to look like more than just hype.

Amazon, CoreWeave, and Equinix will all profit from the AI boom.

Amazon's cloud growth should lead to massive profit expansion.

Nvidia stock has risen nearly tenfold since the start of the artificial intelligence (AI) revolution.

The future revenue opportunity could be big.

S&P 500 earnings are poised to rise this year at the fastest rate since 2021, when earnings soared after recovering from the pandemic.

I have been loading up on Iren and Netlist for more than a year, and I'm not stopping anytime soon.

Ann Arbor, Michigan--(Newsfile Corp. - October 6, 2026) - Nutshell, the CRM and marketing automation platform that helps teams...

AUSTIN, Texas, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Equity Insider News Commentary - The global market for artificial intelligence in drug discovery is projected to grow from $5.09 billion in 2026 to $17.56 billion by 2031, a compound annual growth rate of 28.1%, according to MarketsandMarkets. As that spending moves from pilots into discovery workflows, the enterprise software industry has converged on a new layer between an organization’s data and the AI agents that act on it, variously called an ontology, a semantic layer or a context layer. The open question for life sciences is whether a layer built to describe a business can also describe biology. Active Companies from around the markets with current developments this week include: MindWalk Holdings Corp. (NASDAQ: HYFT), Palantir Technologies Inc. (NASDAQ: PLTR), Snowflake Inc. (NYSE: SNOW), Microsoft Corporation (NASDAQ: MSFT), Veeva Systems Inc. (NYSE: VEEV).